Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells.

Functional endothelial-like cells (EC) have been successfully derived from different cell sources and potentially used for treatment of cardiovascular diseases; however, their relative therapeutic efficacy remains unclear. We differentiated functional EC from human bone marrow mononuclear cells (BM-...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wing-Hon Lai, Jenny C Y Ho, Yau-Chi Chan, Joyce H L Ng, Ka-Wing Au, Lai-Yung Wong, Chung-Wah Siu, Hung-Fat Tse
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0178d1874bb6403b8dadea718796450e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0178d1874bb6403b8dadea718796450e
record_format dspace
spelling oai:doaj.org-article:0178d1874bb6403b8dadea718796450e2021-11-18T07:54:54ZAttenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells.1932-620310.1371/journal.pone.0057876https://doaj.org/article/0178d1874bb6403b8dadea718796450e2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23472116/?tool=EBIhttps://doaj.org/toc/1932-6203Functional endothelial-like cells (EC) have been successfully derived from different cell sources and potentially used for treatment of cardiovascular diseases; however, their relative therapeutic efficacy remains unclear. We differentiated functional EC from human bone marrow mononuclear cells (BM-EC), human embryonic stem cells (hESC-EC) and human induced pluripotent stem cells (hiPSC-EC), and compared their in-vitro tube formation, migration and cytokine expression profiles, and in-vivo capacity to attenuate hind-limb ischemia in mice. Successful differentiation of BM-EC was only achieved in 1/6 patient with severe coronary artery disease. Nevertheless, BM-EC, hESC-EC and hiPSC-EC exhibited typical cobblestone morphology, had the ability of uptaking DiI-labeled acetylated low-density-lipoprotein, and binding of Ulex europaeus lectin. In-vitro functional assay demonstrated that hiPSC-EC and hESC-EC had similar capacity for tube formation and migration as human umbilical cord endothelial cells (HUVEC) and BM-EC (P>0.05). While increased expression of major angiogenic factors including epidermal growth factor, hepatocyte growth factor, vascular endothelial growth factor, placental growth factor and stromal derived factor-1 were observed in all EC cultures during hypoxia compared with normoxia (P<0.05), the magnitudes of cytokine up-regulation upon hypoxic were more dramatic in hiPSC-EC and hESC-EC (P<0.05). Compared with medium, transplanting BM-EC (n = 6), HUVEC (n = 6), hESC-EC (n = 8) or hiPSC-EC (n = 8) significantly attenuated severe hind-limb ischemia in mice via enhancement of neovascularization. In conclusion, functional EC can be generated from hECS and hiPSC with similar therapeutic efficacy for attenuation of severe hind-limb ischemia. Differentiation of functional BM-EC was more difficult to achieve in patients with cardiovascular diseases, and hESC-EC or iPSC-EC are readily available as "off-the-shelf" format for the treatment of tissue ischemia.Wing-Hon LaiJenny C Y HoYau-Chi ChanJoyce H L NgKa-Wing AuLai-Yung WongChung-Wah SiuHung-Fat TsePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 3, p e57876 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Wing-Hon Lai
Jenny C Y Ho
Yau-Chi Chan
Joyce H L Ng
Ka-Wing Au
Lai-Yung Wong
Chung-Wah Siu
Hung-Fat Tse
Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells.
description Functional endothelial-like cells (EC) have been successfully derived from different cell sources and potentially used for treatment of cardiovascular diseases; however, their relative therapeutic efficacy remains unclear. We differentiated functional EC from human bone marrow mononuclear cells (BM-EC), human embryonic stem cells (hESC-EC) and human induced pluripotent stem cells (hiPSC-EC), and compared their in-vitro tube formation, migration and cytokine expression profiles, and in-vivo capacity to attenuate hind-limb ischemia in mice. Successful differentiation of BM-EC was only achieved in 1/6 patient with severe coronary artery disease. Nevertheless, BM-EC, hESC-EC and hiPSC-EC exhibited typical cobblestone morphology, had the ability of uptaking DiI-labeled acetylated low-density-lipoprotein, and binding of Ulex europaeus lectin. In-vitro functional assay demonstrated that hiPSC-EC and hESC-EC had similar capacity for tube formation and migration as human umbilical cord endothelial cells (HUVEC) and BM-EC (P>0.05). While increased expression of major angiogenic factors including epidermal growth factor, hepatocyte growth factor, vascular endothelial growth factor, placental growth factor and stromal derived factor-1 were observed in all EC cultures during hypoxia compared with normoxia (P<0.05), the magnitudes of cytokine up-regulation upon hypoxic were more dramatic in hiPSC-EC and hESC-EC (P<0.05). Compared with medium, transplanting BM-EC (n = 6), HUVEC (n = 6), hESC-EC (n = 8) or hiPSC-EC (n = 8) significantly attenuated severe hind-limb ischemia in mice via enhancement of neovascularization. In conclusion, functional EC can be generated from hECS and hiPSC with similar therapeutic efficacy for attenuation of severe hind-limb ischemia. Differentiation of functional BM-EC was more difficult to achieve in patients with cardiovascular diseases, and hESC-EC or iPSC-EC are readily available as "off-the-shelf" format for the treatment of tissue ischemia.
format article
author Wing-Hon Lai
Jenny C Y Ho
Yau-Chi Chan
Joyce H L Ng
Ka-Wing Au
Lai-Yung Wong
Chung-Wah Siu
Hung-Fat Tse
author_facet Wing-Hon Lai
Jenny C Y Ho
Yau-Chi Chan
Joyce H L Ng
Ka-Wing Au
Lai-Yung Wong
Chung-Wah Siu
Hung-Fat Tse
author_sort Wing-Hon Lai
title Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells.
title_short Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells.
title_full Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells.
title_fullStr Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells.
title_full_unstemmed Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells.
title_sort attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/0178d1874bb6403b8dadea718796450e
work_keys_str_mv AT winghonlai attenuationofhindlimbischemiainmicewithendotheliallikecellsderivedfromdifferentsourcesofhumanstemcells
AT jennycyho attenuationofhindlimbischemiainmicewithendotheliallikecellsderivedfromdifferentsourcesofhumanstemcells
AT yauchichan attenuationofhindlimbischemiainmicewithendotheliallikecellsderivedfromdifferentsourcesofhumanstemcells
AT joycehlng attenuationofhindlimbischemiainmicewithendotheliallikecellsderivedfromdifferentsourcesofhumanstemcells
AT kawingau attenuationofhindlimbischemiainmicewithendotheliallikecellsderivedfromdifferentsourcesofhumanstemcells
AT laiyungwong attenuationofhindlimbischemiainmicewithendotheliallikecellsderivedfromdifferentsourcesofhumanstemcells
AT chungwahsiu attenuationofhindlimbischemiainmicewithendotheliallikecellsderivedfromdifferentsourcesofhumanstemcells
AT hungfattse attenuationofhindlimbischemiainmicewithendotheliallikecellsderivedfromdifferentsourcesofhumanstemcells
_version_ 1718422769967824896